3Cavalieri E, Rogan E, Chakravarti D. The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. Methods Enzymol,2004, 382 : 293-319.
4Sarbia M, Bitzer M, Siegel D, et al. Association between NAD (P)H: quinone oxidoreductase 1 ( NQ01 ) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.Int J Cancer,2003, 107 : 381-386.
5Sommer SS, Groszbach AR, Bottema CD. PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known single-base changes. Biotechniques, 1992,12:82-87.
6Nioi P, Hayes JD. Contribution of NAD (P) H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrt2 basic-region leucine zipper and the arylhydrecarbon receptor basic helix-loop-helix transcription factors. Mutat Res, 2004, 555: 149-171.
7Phillips RM, Basu S. Biological and Clinical Significance of Polymorphisms in NAD(P) H : Quinone Oxidoreductase 1 ( NQO1 ).Current Pharmacogenomics, 2004, 2: 75-82.
8Chen S,Wu K B,Richard Knox.Structure-function studies of DT-diaphorase (NQO1) and NRH quinone oxidoreductase (NQO2)[J].Free Radical Biology & Medicine,2000,29 (4):276-284.
9Tara Fryatt,Hanna I.Pettersson,Walter T,et al.Novel quinolinequinone antitumor agents:structure metabolism studies with NAD (P) H:quinone oxidoreductase (NQO1)[J].Bioorganic &Medicinal Chemistry,2004,12 (7):1667-1687.
10Yin L H,Pu Y P,Liu T Y.Genetic polymorphisms of NAD (P)H quinine oxidoreductase,CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing[J].China.Lung Cancer,2001,33 (2-3):133-141.
